Summary
Northrop Grumman Corporation (NOC) reported strong financial results for the second quarter and first half of 2020, demonstrating resilience amidst the COVID-19 pandemic. Total sales increased by 5% for both periods, reaching $8.88 billion in Q2 and $17.50 billion year-to-date, driven by growth across all four operating segments: Aeronautics Systems, Defense Systems, Mission Systems, and Space Systems. Net earnings saw a significant increase of 17% in Q2 and 9% year-to-date, with diluted EPS growing by 19% and 10% respectively. The company also reported a substantial increase in operating cash flow and free cash flow, significantly improved by CARES Act provisions and increased DoD progress payments. Despite global uncertainties, Northrop Grumman maintained a positive outlook for the remainder of the year, with a robust backlog of $70 billion providing visibility into future revenue. The company's balance sheet remains strong with $4.2 billion in cash and cash equivalents as of June 30, 2020. Management's strategic actions, including the issuance of $2.25 billion in senior notes, have bolstered financial flexibility. While acknowledging potential impacts from COVID-19, including increased costs and productivity reductions, the company has implemented robust measures to protect employees and ensure operational continuity. The company's diversified business and strong government customer relationships position it well to navigate the current economic climate and continue delivering critical defense and aerospace solutions.
Financial Highlights
50 data points| Revenue | $8.88B |
| Operating Expenses | $7.89B |
| Operating Income | $994.00M |
| Net Income | $1.00B |
| EPS (Basic) | $6.02 |
| EPS (Diluted) | $6.01 |
| Shares Outstanding (Basic) | 166.90M |
| Shares Outstanding (Diluted) | 167.30M |
Key Highlights
- 1Total sales increased by 5% to $8.88 billion in Q2 2020 and 5% to $17.50 billion year-to-date, demonstrating continued revenue growth.
- 2Net earnings rose significantly by 17% in Q2 2020 to $1.005 billion and by 9% year-to-date to $1.873 billion.
- 3Diluted earnings per share (EPS) saw robust growth, up 19% in Q2 2020 to $6.01 and 10% year-to-date to $11.16.
- 4Operating cash flow significantly improved, increasing by 94% year-to-date to $1.344 billion, aided by CARES Act provisions and increased DoD progress payments.
- 5Free cash flow saw a substantial increase of 408% year-to-date, reaching $803 million.
- 6The company ended the period with a strong backlog of $70.0 billion, providing excellent revenue visibility.
- 7Cash and cash equivalents stood at a healthy $4.178 billion as of June 30, 2020, bolstered by a recent debt issuance.